FDA clears tremor monitoring module as Neu Health launches phone-based tech that detects subtle indicators of neurological decline. <\/p>\n
British health tech startup Neu Health<\/a> has launched its smartphone-based platform for the detection and management of Parkinson\u2019s disease and dementia in the US market. Neu\u2019s platform aims to turns any smartphone into a clinical-grade assessment tool for neurological health.<\/p>\n The company\u2019s US launch coincides with receiving FDA 510(k) clearance for its \u201ctremor measurement\u201d module, which the company claims is the first to quantify motor symptoms in adults with mild to moderate Parkinson\u2019s using only a phone, without requiring wearable devices or specialized hardware.<\/p>\n Neu\u2019s platform uses smartphone sensor data to detect changes that may precede visible neurological decline. Patients complete short, guided tasks from home, such as speaking, tapping, moving or recalling words, which are analyzed by algorithms trained on more than a decade of longitudinal Parkinson\u2019s data. The phone\u2019s sensors capture speech patterns, motor performance, memory and cognitive function, generating digital biomarkers and predictive scores that reveal subtle changes often missed in routine visits.<\/p>\n \u201cPeople often overlook voice or gait changes because they assume they\u2019re minor, but they\u2019re among the earliest and most actionable signals of neurological decline,\u201d said Neu\u2019s Chief Medical Officer Dr Kinan Muhammed. \u201cBy capturing these subtle shifts longitudinally and objectively, Neu allows us to anticipate deterioration, personalize treatment and reduce the burden on patients, caregivers and care teams alike.\u201d<\/p>\n The platform is designed to shift neurological care from reactive to proactive, addressing the often long gaps between clinic visits that leave patients and families without structured support as symptoms progress.<\/p>\n \u201cFor too long, we\u2019ve treated brain health reactively, standing by until someone is visibly declining before stepping in,\u201d said Neu Health CEO Caroline Cake. \u201cWe can no longer wait for accidents to happen to justify the next level of care for our loved ones. Neu offers health systems a new path forward, where high-frequency monitoring, predictive insights and home-based tools expand the reach of neurologists, relieve pressure on frontline staff and raise the standard of care for millions of patients and families.\u201d<\/p>\n Neu\u2019s entry into the US builds on more than a decade of research and validation in the UK, where it has been deployed in NHS Trusts. Early deployments in the UK suggest the platform can detect neurological changes earlier than conventional assessments, sometimes by as much as 18 months. Its digital phenotyping methods have been presented in peer-reviewed publications, including Neurology<\/a> and the Journal of Neurology, Neurosurgery & Psychiatry<\/a>.<\/p>\n Neu is now pursuing partnerships with US health systems and payers, and revealed its platform is already being used in Parkinson\u2019s care at Mass General Brigham. The company says it is focused on expanding access to specialist-level brain care in the US, including in underserved rural communities where traditional clinic-based care can be difficult to access.<\/p>\n Photographs courtesy of Neu Health. <\/p>\n","protected":false},"excerpt":{"rendered":"FDA clears tremor monitoring module as Neu Health launches phone-based tech that detects subtle indicators of neurological decline.…\n","protected":false},"author":2,"featured_media":35247,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,9757,32234,32235,137,18220,500,32236,10485,6193,44,32237],"class_list":["post-35246","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-dementia","tag-digital-biomarkers","tag-digital-health","tag-health","tag-health-monitoring","tag-healthcare","tag-healthtech","tag-longevity","tag-neurodegeneration","tag-news","tag-parkinsons"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/35246","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=35246"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/35246\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/35247"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=35246"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=35246"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=35246"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} <\/p>\n
<\/p>\n